[1]
Bondy C. A.: Clinical practice guideline. Care of girls and women with
Turner syndrome: a guideline of the Turner syndrome study group. J Clin
Endocrinol Metab 2007; 92: 10-25.
[2]
Wiśniewski A. Romer T.: Zespół Turnera. „IMED Standardy Medyczne”.
[3]
Tabor A., Starzyk J., Schlegel-Zawadzka M.: Interdisciplinary nature of
the integrated care model for children with Turner Syndrome. Probl Hig
Epidemiol 2006; 87: 372-381.
[4]
Gawlik A., Antosz A., Wilk K.: Opieka medyczna w zespole Turnera
– z praktycznego punktu widzenia. Klinika Pediatrii, Endokrynologii
i Diabetologii Dziecięcej, Śląski Uniwersytet Medyczny w Katowicach,
Katedra Zdrowia Kobiety, Śląski Uniwersytet Medyczny w Katowicach,
Endokrynol Ped 2013; 3(44): 55-70.
[5]
Pinsker J. E.: Turner syndrome: Updating the paradigm of clinical care. J
Clin Endocrinol Metab 2012: 97; 994-1003.
[6]
Stocholm K., Juul S., Juel K., et al.: Prevalence, incidence, diagnostic
delay, and mortality in Turner syndrome; J Clin Endocrinol Metab 2006:
91; 10-25.
[7]
Wiśniewski A.; Zespół Turnera; Klinika Pediatryczna 1997: 5, 3, 249-253
[8]
Stratakis C.A., Rennert O.M.: Turner syndrome: molecular and cytogenetics,
dysmorphology, endocrine, and other clinical manifestations
and their management. Endocrinologist 1994: 4; 442–453. DOI:
10.1097/00019616-199411000-00007.
[9]
Gravholt C.H.: Epidemiological, endocrine and metabolic features in Turner
syndrome. Eur J Endocrinol 2004; 151: 657- 687.
[10]
Davenport M.L.: Approach to the patient with Turner syndrome; J Clin
Endocrinol Metab 2010; 95; 1487-1495.
[11]
Ferguson-Smith M.A.: Karyotype-phenotype correlations in gonadal
dysgenesis and their bearing on the pathogenesis of malformations. J
Med Genet 1965: 2; 142-155.
[12]
Elsheikh M., Wass J.A.H., Conway G.S.: Autoimmune thyroid syndrome
in woman with Turner’s syndrome – the association with karyotype; Clin
Endocrinol 2001: 55; 223-226.
[13]
Ross J.L., Roeltgen D., Kushner H., et al.: The Turner syndrome-associated
neurocognitive phenotype maps to distal Xp. Am J Hum Genet 2000:
67; 672-681.
[14]
Zinn A.R., Roeltgen D., Stefanatos G., et al.: Turner syndrome neurocognitive
phenotype maps to Xp22.3. Behav Brain Funct 2007; 3: 24.
[15]
Saenger P., Albertsson Wikland K., Conway G.S., et al.: Recommendations
for the diagnosis and management of Turner Syndrome, J Clin Endocrinol
and Metab 2001; 86: 3061-3069.
[16]
Davenport M.L., Cornea E., Xia K., et al.: Altered Brain Structure in Infants
with Turner Syndrome. Cereb Cortex. 2020 Mar 21; 30(2): 587-596.
[17]
Łącka K., Zespół Turnera – korelacja pomiędzy kariotypem a fenotypem.
„Endokrynologia Polska”, 2005: 56. 6; 986-983.
[18]
Harsha K.J., Nair J. S.: Chiari I Malformation Associated with Turner
Syndrome. J Neurosci Rural Pract. 2017 Apr-Jun; 8(2): 277-280.
[19]
Araki K., Matsumoto K., Shiraishi T., et al.: Turner’s syndrome with
agenesis of the corpus callosum, Hashimoto’s thyroiditis and horseshoe
kidney. Acta Paediatr Jpn. 1987; 29: 622–626.
[20]
Tombini M., Marciani M..G., Romigi A., et al.: Bilateral frontal
polymicrogyria and epilepsy in a patient with Turner mosaicism: A case
report. J Neurol Sci. 2003; 213: 83–86.
[21]
Striano S., Striano P., Tortora F., et al.: Intractable epilepsy in Turner
syndrome associated with bilateral perisylvian hypoplasia: One case
report. Clin Neurol Neurosurg. 2005; 108: 56–59.
[22]
Jhang K.M., Chang T.M., Chen M., et al.: Generalized epilepsy in a patient
with mosaic Turner syndrome: A case report. J Med Case Rep. 2014;
8: 109.
[23]
Sybert V.P., Bird T.D., Salk D.J.: Pseudotumour cerebri and the Turner
syndrome. J Neurol Neurosurg Psychiatry. 1985; 48: 164–166.
[24]
Naydenov E., Tzekov C., Minkin K., et al.: Malignant progression of
anaplastic supratentorial ganglioglioma into glioblastoma multiforme in
a patient with turner syndrome. J Neurol Surg A Cent Eur Neurosurg.
2012; 73: 253–255.
[25]
Hanaei S., Habibi Z., Nejat F., et al.: Pediatric glioblastoma multiforme in
association with Turner’s syndrome: A case report. Pediatr Neurosurg.
2015; 50: 38–41.
[26]
Ferrier P., Bamatter F., Klein D.: Muscular Dystrophy (Duchenne) in a Girl
with Turner’s Syndrome. „J Med Genet”. 1965: 2 (1); 38-46.
[27]
Sano M., Saito F., Yamamoto K., et al.: Duchenne Muscular Dystrophy in
Female with 45,X/46,XX Chromosome Constitution. Jpn J Human Genet.
1987; 32: 257-262.
[28]
Farooque A.., Atapattu N., Amarasena S., et al.: An association of
craniopharyngioma in Turner syndrome. Pediatr Blood Cancer. 2013; 60:
7–9.
[29]
Lepage J.F., Mazaika P.K., Hong D. S. et al.: Cortical brain morphology
in young, estrogen-naive, and adolescent, estrogen treated girls with
Turner syndrome. Cereb Cortex. 2013; 23: 2159–2168.
[30]
Carel J.C., Ecosse E., Bastie-Sigeac I., et al.: Quality of life determinants in
young women with Turner’s Syndrome after growth hormone treatment:
Results of the StaTur Population-based Cohort Study, w: Journal Clin.
Endocrinol. Metabolism, April 2005; 90(4); pp.1992-1997.
[31]
Carel J.C., Elie C., Ecosse E., et al.: Self-Esteem and Social Adjustment in
Young Women with Turner Syndrome -Influence of Pubertal Management
and Sexuality: Population Based Cohort Study, w: The Journal of Clinical
Endocrinology & Metabolism Vol. 91, No. 8, 2972-2979.
[32]
Ranke M.B.: Turner Syndrome, European Journal of Endocrinology 1999;
141: 216-217.
[33]
Raznahan A., Cutter W., Lalonde F., et al.: Cortical anatomy in human X
monosomy. Neuroimage. 2010; 49: 2915–2923.
[34]
Green T., Chromik L.C., Mazaika P.K., et al.: Aberrant parietal cortex
developmental trajectories in girls with Turner syndrome and related
visual-spatial cognitive development: A preliminary study. Am J Med
Genet B Neuropsychiatr Genet. 2014; 165B: 531–540.
[35]
Raznahan A., Lee Y., Stidd R., et al.: Longitudinally mapping the influence of
sex and androgen signaling on the dynamics of human cortical maturation
in adolescence. Proc Natl Acad Sci U S A. 2010; 107: 16988–16993.
[36]
Marzelli M.J., Hoeft F., Hong D.S., et al.: Neuroanatomical spatial patterns
in Turner syndrome. Neuroimage. 2011; 55: 439–447.
[37]
Lawrence K., Campbell R., Swettenham J., et al.: Interpreting gaze in
Turner syndrome: impaired sensitivity to intention and emotion, but
preservation of social cueing. Neuropsychologia. 2003; 41(8): 894-905.
[38]
Kimura M., Nakajima M., Yoshino K.,:Turner syndrome with agenesis of
the corpus callosum. Am J Med Genet. 1990; 37: 227–228.
[39]
Abd S.E., Wilson L., Howlin P., et al.: Agenesis of the corpus callosum in
Turner syndrome with ring X. Dev Med Child Neurol. 1997; 39: 119–124.
[40]
Lee Y.Y., Hung J., Chang T.Y., et al.: Agenesis of the corpus callosum in
Turner’s syndrome: Report of a case and review of the literature. Acta
Neurol Taiwan. 2008; 17: 194–198.
[41]
Pereira E., Polo M.R., López J.M., Quijano T.A., et al.: Agenesis of the
corpus callosum in a newborn with turner mosaicism. Pediatr Rep. 2014;
6: 5112.
[42]
Baxi L.V., Walsh C.A.: Cerebral venous sinus thrombosis, Dandy-Walker
malformation and polymicrogyria in Turner syndrome: An unreported
association. Prenat Diagn. 2009; 29: 899–900.
[43]
Terao Y., Hashimoto K., Nukina N., et al.: Cortical dysgenesis in a patient
with Turner mosaicism. Dev Med Child Neurol. 1996; 38: 455–460.
[44]
Molko N., Cachia A., Riviere D., et al.: Brain anatomy in Turner syndrome:
Evidence for impaired social and spatial-numerical networks. Cereb
Cortex. 2004; 14: 840–850.
[45]
Yamagata B., Barnea-Goraly N., Marzelli M.J., et al.: White matter
aberrations in prepubertal estrogen naive girls with monosomic Turner
Syndrome. Cereb Cortex. 2012; 22: 2761–2768.
[46]
Bray S., Hoeft F., Hong D.S., et al.: Aberrant functional network recruitment
of posterior parietal cortex in Turner syndrome. Hum Brain Mapp. 2013;
34: 3117–3128.
[47]
Kesler S.R., Garrett A., Bender B., et al.: Amygdala and hippocampal
volumes in Turner syndrome: A high-resolution MRI study of
X-monosomy. Neuropsychologia. 2004; 42: 1971–1978.
[48]
Murphy D.G., DeCarli C., Daly E., et al.: X-chromosome effects on female
brain: A magnetic resonance imaging study of Turnerfs syndrome.
Lancet. 1993; 342: 1197–200.
[49]
Fryer S.L., Kwon H., Eliez S., et al.: Corpus callosum and posterior fossa
development in monozygotic females: A morphometric MRI study of
Turner syndrome. Dev Med Child Neurol. 2003; 45(5): 320-324.
[50]
Zhao Q., Zhang Z., Xie S., et al.: Cognitive impairment and gray/white
matter volume abnormalities in pediatric patients with Turner syndrome
presenting with various karyotypes. J Pediatr Endocrinol Metab. 2013;
26: 1111–1121.
[51]
Cutter W.J., Daly E.M., Robertson D.M., et al.: Influence of X chromosome
and hormones on human brain development, A magnetic resonance
imaging and proton magnetic resonance spectroscopy study of Turner
syndrome. Biol Psychiatry. 2006; 59: 273–283.
[52]
Lepage J.F., Clouchoux C., Lassonde M., et al.: Cortical thickness
correlates of socioemotional difficulties in adults with Turner syndrome.
Psychoneuroendocrinology. 2014; 44: 30–34.
[53]
Brown W.E., Kesler S.R., Eliez S., et al.: Brain development in Turner
syndrome: A magnetic resonance imaging study. Psychiatry Res. 2002;
116: 187–196.
[54]
Kesler S.R., Blasey C.M., Brown W.E., et al.: Effects of X-monosomy and
X-linked imprinting on superior temporal gyrus morphology in Turner
syndrome. Biol Psychiatry. 2003; 54: 636–646.
[55]
Reiss A.L., Mazzocco M.M., Greenlaw R., et al.: Neurodevelopmental
effects of X monosomy: A volumetric imaging study. Ann Neurol. 1995;
38: 731–738.
[56]
Vulliemoz S., Dahoun S., Seeck M.,: Bilateral temporal lobe epilepsy in
a patient with Turner syndrome mosaicism. Seizure. 2007; 16: 261–265.
[57]
Mózg, umysł i zachowanie, www.is.umk.pl [dostęp 2017-11-26] (pol.).
[58]
Bickart, K. C., Wright, C. I., Dautoff, R. J., et al.: Amygdala volume
and social network size in humans. Nature Neuroscience 2011; 14(2):
163-164.
[59]
Skuse D.H., Morris J.S., Dolan R.J.: Functional dissociation of amygdala-
modulated arousal and cognitive appraisal, in Turner syndrome. Brain.
2005 Sep; 128(Pt 9): 2084-2096.
[60]
Reiss A.L., Freund L., Plotnick L., et al.: The effects of X monosomy on
brain development: monozygotic twins discordant for Turner’s syndrome.
Ann Neurol. 1993 Jul; 34(1): 95-107.
[61]
Beaton E.A., Stoddard J., Lai S., et al.: Atypical functional brain activation
during a multiple object tracking task in girls with Turner syndrome:
Neurocorrelates of reduced spatiotemporal resolution. Am J Intellect
Dev Disabil. 2010; 115: 140–156.
[62]
Kesler S.R., Haberecht M.F., Menon V., et al.: Functional neuroanatomy of
spatial orientation processing in Turner syndrome. Cereb Cortex. 2004;
14: 174–180.
[63]
Tamm L., Menon V., Reiss A.L., Abnormal prefrontal cortex function during
response inhibition in Turner syndrome: Functional magnetic resonance
imaging evidence. Biol Psychiatry. 2003; 53: 107–111.
[64]
Haberecht M.F., Menon V., Warsofsky I.S., et al.: Functional neuroanatomy
of visuo-spatial working memory in Turner syndrome. Hum Brain Mapp.
2001; 14: 96–107.
[65]
Bray S., Dunkin B., Hong D.S., et al.: Reduced functional connectivity
during working memory in Turner syndrome. Cereb Cortex. 2011; 21:
2471–2481.
[66]
Hart S.J., Davenport M.L., Hooper S.R., et al.: Visuospatial executive
function in Turner syndrome: Functional MRI and neurocognitive
findings. Brain. 2006; 129(Pt 5): 1125–1136.
[67]
Trevisol-Bittencourt P.C., Sander J.W.: Epilepsy and Turner’s syndrome:
report of a case and review of the literature. Arq Neuropsiquiatr 1990;
48: 360–365.
[68]
Magara S.I., Kawashima H., Kobayashi Y., et al.: Rub epilepsy in an infant
with Turner syndrome. Brain Dev 2014 Dec 2. pi: S0387 7604 (14)
00265-4.
[69]
Zeng Y.J., Yang X.S., Tian F.F., et al.: A case of Turner syndrome combined
with epilepsy. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2004; 29: 364.
[70]
Puusepp H., Zordania R., Paal M., et al.: Girl with partial Turner syndrome
and absence epilepsy. Pediatr Neurol 2008; 38: 289-292.
[71]
Bartocci A., Striano P., Mancardi M.M., et al.: Partial monosomy Xq (Xq23
qter) and trisomy 4p (4p15.33 pter) in a woman with intractable focal
epilepsy, borderline intellectual functioning, and dysmorphic features.
Brain Dev 2008; 30: 425-429.
[72]
Joost K., Tammur P., Teek R., et al.: Whole Xp deletion in a girl with mental
retardation, epilepsy, and biochemical features of OTC deficiency. Mol
Syndromol 2011; 1: 311-315.
[73]
Daly R.F., Patau K., Therman E., et al.: Structure and Barr body formation
of an Xp + chromosome with two inactivation centers. Am J Hum Genet
1977; 29: 83–93.
[74]
Grosso S., Farnetani M.A., Di Bartolo R.M., et al.: Electroencephalographic
and epileptic patterns in X chromosome anomalies. J Clin Neurophysiol
2004; 21:2 49–253.
[75]
Tartaglia N.R., Howell S., Sutherland A., et al.: A review of trisomy X
(47,XXX). Orphanet J Rare Dis. 2010 May 11; 5: 8.
[76]
Sybert V.P, McCauley E.: Turner’s syndrome. N Engl J Med 2004;
351:1227–1238.
[77]
Gersak K., Veble A.: Low-level X chromosome mosaicism in women with
sporadic premature ovarian failure. Reprod Biomed Online 2011; 22:
399–403
[78]
Roubertie A., Humbertclaude V., Leydet J., et al.: Partial epilepsy and 47,
XXX karyotype: report of four cases. Pediatr Neurol 2006; 35: 69–74.
[79]
Irioka T., Mizusawa H.,: Ischemic stroke in a young adult with Turner
syndrome. Neurol Sci. 2011; 32: 317–319.
[80]
Terasaki T., Hashimoto Y., Miyashita F., et al.: A case of Turner syndrome
complicated with brain infarction. Rinsho Shinkeigaku. 2002 Feb; 42(2):
145-148. Japanese.
[81]
Manjila S., Miller B.R., Rao-Frisch A., et al.: Moyamoya disease associated
with asymptomatic mosaic Turner syndrome: a rare cause of hemorrhagic
stroke. Stroke Cerebrovasc Dis. 2014 May Jun; 23(5): 1242-1244.
[82]
Amelot A., Lemaistre G., Cornu P., et al.: Multiple meningiomas in patients
with Turner syndrome. Acta Neurochir (Wien) 2015; 157 :621–623.
[83]
Wells G.D., O’Gorman C.S., Rayner T., et al.: Skeletal muscle abnormalities
in girls and adolescents with Turner syndrome. J Clin Endocrinol Metab
2013 Jun; 98(6): 2521-2527.
[84]
Twardowski A., Łącka K., Ławniczak M.: Wspomaganie psychospołecznego
rozwoju osób z zespołem Turnera, (w:) A. Twardowski (red.),
Wspomaganie rozwoju dzieci z rzadkimi zespołami genetycznymi,
Wydawnictwo „GEN”, Poznań 2009.
[85]
Milde K., Sienkiewicz E., Domino G., et al.: Analysis of selected strength
variables in girls with Turner’s syndrome. Papers on Anthropology
University of Tartu 2003; 12: 167-172.
[86]
Amundson E., Boman U.W., Barrenäs M.L., et al.: Impact of growth
hormone therapy on quality of life in adults with turner syndrome. J Clin
Endocrinol Metab 2010 Mar; 95(3): 1355-1359.
[87]
El-Mansoury M., Barrenäs M.L., Bryman I., et al.;. Impaired body balance,
fine motor function and hearing in women with Turner syndrome. Clin
Endocrinol 2009; 71(2): 273-278.
[88]
Saad K., Abdelrahman A.A., Abdel-Raheem Y.F et al.: Turner syndrome:
review of clinical, neuropsychiatric, and EEG status: an experience of
tertiary center. Acta Neurol Belg 2014; 114(1): 1-9.
[89]
Lepage J., Clouchoux C., Lassonde M., et al.: Abnormal motor cortex
excitability is associated with reduced cortical thickness in X monosomy.
Hum Brain Mapp 2013; 34: 936-944.
[90]
Hong D., Scaletta Kent J., Kesler S.: Cognitive profile of Turner syndrome.
Dev Disabil Res Rev 2009; 15(4): 270-278.
[91]
Ganou M., Grouios G.: Cerebral laterality in Turner syndrome: a critical
review of the literature. Child Neuropsychol 2008 Mar; 14(2): 135- 147.
[92]
Nijhuis-van der Sanden M.W., Eling P.A., Otten B.J.: A review of
neuropsychological and motor studies in Turner syndrome. Neurosci
Biobehav Rev 2003 Sep; 27(4): 329-338.
[93]
Chelly J., Marlhnes F., Le Maarec B., et al.: De novo DNA microdeletion
in a girl with Turner syndrome and Duchenne muscular dystrophy. Hum
Genet. 1986; 74: 193-196.
[94]
Lesniak-Karpiak K, Mazzocco MM, Ross JL. Behavioral assessment of
social anxiety in females with Turner or fragile X syndrome. J Autism
Dev Disord. 2003 Feb; 33(1): 55-67.
[95]
Ou Z., Li S., Chen X., et al.: Duchenne Muscular Dystrophy in Female Patient
with a Karyotype of 46,Xi(X)(q10). Tohoku J Exp Med. 2010; 222: 149-153.
[96]
Kaczorowska E., Zimowski J., Cichoń-Kotek M., et al.: Co-incidence
of Turner syndrome and Duchenne muscular dystrophy -an important
problem for the clinician. Dev Period Med. 2016; 20(4): 273-278.
[97]
Kaczorowska E., Poysky J., Shapiro F., et al.: DMD Care Considerations
Working Group. Diagnosis and management of Duchenne muscular
dystrophy. Part 1: diagnosis and pharmacological and psychosocial
management. LancetNeurol. 2010; 9: 77-93.
[98]
Bushby K., Finkel R., Birnkrant D.J., et al.: Diagnosis and management of
Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological
and psychosocial management. DMD Care Considerations Working
Group Lancet Neurol. 2010 Jan; 9(1): 77-93.
[99]
Darras B.T., Miller D.T, Urion D.K.: Dystrophinopathies.2000 Sep 5
[Updated 2014 Nov 26]. In: Pagon RA, Adam MP, Ardinger HH, et
al., editors. GeneReviews® [Internet]. Seattle (WA): University of
Washington, Seattle; 1993-2016.
[100]
Felisari G., Martinelli Boneschi F., Bardoni A., et al.: Loss of Dp140
dystrophin isoform and intellectual impairment in Duchenne dystrophy.
Neurology 2000; 55: 559-564.
[101]
Voudouris N. J., Greenwood K. M.: Duchenne muscular dystrophy: Full-
scale, verbal and performance intelligence quotients. Dev Med Child
Neurol. 2001; 43: 497-501, cognition, brain structure and function. Curr
Opin Neurol 2012; 25: 144–149.
[102]
Catharine S., Creswell & David H.: Autism in association with Turner
syndrome: Genetic implications for male vulnerability to pervasive
developmental disorders, Neurocase, 5: 6, 511-518,
[103]
Russell H.F., Wallis D., Mazzocco M.M., Moshang T., et al.: Increased
Prevalence of ADHD in Turner Syndrome with No Evidence of Imprinting
Effects. J Pediatr Psychol. 2006; 31: 945–55.
[104]
Kawanishi C., Kono M., Onishi H., et al.: A case of Turner syndrome
with schizophrenia: genetic relationship between Turner syndrome and
psychosis. Psychiatry Clin Neurosci. 1997; 51(2): 83–85.
[105]
Catinari S., Vass A., Heresco-Levy U.: Psychiatric manifestations in
Turner Syndrome: a brief survey. Isr J Psychiatry Relat Sci. 2006; 43(4):
293–295.
[106]
Knickmeyer R.C., Davenport M., Turner syndrome and sexual
differentiation of the brain: implications for understanding male-biased
neurodevelopmental disorders. J Neurodev Disord. 2011; 3(4): 293–306.
[107]
Kesler S.R. at al.: Turner Syndrome Article Literature Review (PDF
Available) in Child and Adolescent Psychiatric Clinics of North America,
August 2007; 16(3): 709-722 ·
[108]
Lepage J. F., Lortie M., Deal C. L., et al.: Empathy, autistic traits, and
motor resonance in adults with Turner syndrome. Soc Neurosci. 2014;
9(6): 601-609.
[109]
Moss J., Howlin P.: Autism spectrum disorders in genetic syndromes:
implications for diagnosis, intervention and understanding the wider
autism spectrum disorder population. J Intellect Disabil Res. 2009 Oct;
53(10): 852-873.
[110]
Pierpont E. I., Tworog-Dube E., Roberts A. E.: Attention skills and
executive functioning in children with Noonan syndrome and their
unaffected siblings. Dev Med Child Neurol. 2015; 57: 385–392.
[111]
Brown W. E., Kesler S. R., Eliez S., et al.: A volumetric study of parietal
lobe subregions in Turner syndrome. Dev Med Child Neurol. 2004; 46:
607–609.
[112]
Holzapfel M., Barnea-Goraly N., Eckert M.A., et al.: Selective Alterations
of White Matter Associated with Visuospatial and Sensorimotor
Dysfunction in Turner Syndrome. J Neurosci. 2006; 26: 7007–7013.
[113]
Dołęga Z., Irzyniec T.: The social contex of the atypical development
of girls and women with Turner syndrome. Psychological Journal,
2015;21:65-72
[114]
Carlone C., Pompili E., Silvestrini C., et al.: Aripiprazole once-monthly as
treatment for psychosis in Turner syndrome: literature review and case
report. Riv Psichiatr. 2016 Jul-Aug; 51(4): 129-134. English.
[115]
Cardoso G., Daly R., Haq N. A., et al.: Current and lifetime psychiatric
illness in women with Turner syndrome. Gynecol Endocrinol. 2004;
19(6): 313–319.
[116]
Roser P., Kawohl W.: Turner syndrome and schizophrenia: a further hint
for the role of the X-chromosome in the pathogenesis of schizophrenic
disorders. World J Biol Psychiatry 2010; 11: 239-242.
[117]
Słopień A., Salagierska J., Domowicz K., et.al.: Psychotic depression
with Turner’s syndrome and autism spectrum disorder, Klinika Psychiatrii
Dzieci i Młodzieży, Uniwersytet Medyczny w Poznaniu. Neuropsychiatria
i Neuropsychologia 2017; 12, 1: 38–46
[118]
Smith E. N., Romero C., Donovan B., et al.: Emotion theories and
adolescent well-being: Results of an online intervention. Emotion. 2018
Sep; 18(6): 781-788.
[119]
Bathla M., Singh M., Relan P.: Prevalence of anxiety and depressive
symptoms among patients with hypothyroidism. Indian J Endocrinol
Metab. 2016 Jul-Aug; 20(4): 468-474.
[120]
Gabrielle E., Reimann B. S., Martha M. et al.: Psychosocial Characteristics
of Women with a Delayed Diagnosis of Turner Syndrome. J Pediatr. 2018
Aug; 199: 206-211.
[121]
Wei-Dong Y., Chun-Fang W.: Exploring the Genetic Underpinnings of
Brain and Behavioral Disorders, „Journal of Neurogenetics”, 28 (1-2),
2014: 1–4.
[122]
Hall J. G., Sybert V., Williamson R. A., et al.: Turner’s Syndrome (specialty
conference). “The Western Journal of Medicine”, 1982; 137: 32-44.
[123]
Leppig K. A., Sybert V. P., Ross J. L., et al.: Phenotype and X inactivation
in 45,X/46,X,r (X) cases, “American Journal of Human Gene-tics”, 2004;
128: 276-284.
[124]
Siegel P., Clopper R., Stabler B.: The psychological consequences of
Turner Syndrome and Review of the National Cooperative Growth Study
Psychological Substudy, “Official Journal of the American Academy of
Pediatrics”,1998; 102: 488-491.
[125]
Wikiera B., Noczyńska A..: Dziecko z zespołem Turnera, Katedra i Klinika
Endokrynologii i Diabetologii Wieku Rozwojowego, Akademia Medyczna
Wrocław 2009.
[126]
Jeż W.: Kobiety z zespołem Turnera. Pomiar jakości życia, próba
zastosowania pomocy, Wydawnictwo Śląskiej Akademii Medycznej,
Katowice 1999.
[127]
Bruandet M., Molko N., Cohen L., et al.: A cognitive characterization of
dyscalculia in Turner Syndrome, “Neuropsychologia”, 2004; 42: 288-298.
[128]
Mazzocco M. M.: A process approach to describing mathematics
difficulties in girls with Turner syndrome, “Official Journal of the
American Academy of Pediatrics”,1998; 102, 3: 492-496.
[129]
Zadrożna I.: Zespół Turnera, Nieznane? Poznane Zaburzenia rozwojowe
u dzieci z rzadkimi zespołami genetycznymi i wadami wrodzonymi,
wydawnictwo naukowe UAM, Poznań 2013.
Scholar Google
PubMed